Search

Displaying results 1521 - 1530 of 10000 in total
  1. Drug

    Acrothecium robustum

    go.drugbank.com/drugs/DB10840
    Approved

    Acrothecium robustum is a fungus which can provoke allergic reactions. Acrothecium robustum extract is used in allergenic testing.

    Mixtures: Treatment Set TS128871
  2. Drug

    Microsporum canis

    go.drugbank.com/drugs/DB10843
    Approved

    Microsporum canis is a fungus which can provoke allergic reactions. Microsporum canis extract is used in allergenic testing.

    Mixtures: Treatment Set TS128871
  3. Drug

    Doravirine

    go.drugbank.com/drugs/DB12301
    ApprovedInvestigational

    [L12729,L4562] Doravirine is available by itself or as a combination product of doravirine (100 mg), lamivudine (300 mg), and tenofovir disoproxil fumarate (300 mg). … Doravirine is an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) intended to be administered in combination with other antiretroviral medicines.

    Categories: Antivirals for Systemic Use, Antiinfectives for Systemic Use
  4. Drug

    Relebactam

    go.drugbank.com/drugs/DB12377
    ApprovedInvestigational

    [label] It is considered to be a last-line treatment option and gained FDA approval as part of the combination product RecarbrioⓇ in July 2019.[L7568] … Relebactam is a diazabicyclooctane beta-lactamase inhibitor, similar in structure to [avibactam].

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  5. Drug

    Trifarotene

    go.drugbank.com/drugs/DB12808
    ApprovedInvestigational

    as compared to older, less selective retinoids. … Trifarotene is a topical retinoid cream used in the treatment of acne vulgaris that was first approved for use in the United States in October 2019.

    Categories: Anti-Acne Preparations for Topical Use, Retinoids for Topical Use in Acne
  6. Drug

    Loxoprofen

    go.drugbank.com/drugs/DB09212
    ApprovedInvestigational

    A transdermal preparation was approved for use in Japan in January 2006. … It is marketed under the trade name Loxonin in Brazil, Mexico and Japan by Sankyo, as Loxomac in India, and as Oxeno in Argentina.

    Categories: Antiinflammatory Preparations, Non-Steroids for Topical Use
  7. Drug

    Aspergillus repens

    go.drugbank.com/drugs/DB10449
    Approved

    Aspergillus repens is a fungus which can provoke allergic reactions. Aspergillus repens extract is used in allergenic testing.

    Mixtures: Treatment Set TS333938
  8. Drug

    Abciximab

    go.drugbank.com/drugs/DB00054
    ApprovedWithdrawn

    Abciximab is a Fab fragment of the chimeric human-murine monoclonal antibody 7E3.

  9. Drug

    Paritaprevir

    go.drugbank.com/drugs/DB09297
    ApprovedInvestigational

    burden compared to older agents such as [DB08873], [DB05521], [DB00008], [DB00022], and [DB00811]. … Paritaprevir is also available as a fixed-dose combination product with [DB09296] and [DB00503] as the FDA- and Health Canada-approved product Technivie.

    Categories: Antivirals for Systemic Use, Antiinfectives for Systemic UseSynonyms: (2R,6S,12Z,13aR,14aR,16aS)-N-(cyclopropanesulfonyl)-6-[(5-methylpyrazine-2-carbonyl)amino]-5,16-dioxo-2-[(phenanthridin-6-yl)oxy]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo
  10. Drug

    Streptomyces griseus

    go.drugbank.com/drugs/DB10826
    Approved

    Streptomyces griseus allergenic extract is used in allergenic testing.

    Mixtures: Treatment Set TS128871